Navigation Links
Reportlinker Adds Pharmaceutical Management of Obesity (Technical Insights)
Date:5/19/2011

NEW YORK, May 19, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmaceutical Management of Obesity (Technical Insights)

http://www.reportlinker.com/p0503653/Pharmaceutical-Management-of-Obesity-Technical-Insights.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication

The field of obesity management is seeing a lot of research and product development activities.This research service provides a detailed analysis of the technology developments and industry dynamics for obesity drugs. An evaluation of the adoption of obesity drugs has been discussed (regionwise) and some of the emerging areas of obesity research has also been highlighted. Some of the key industry drivers and challenges along with their market impact have been discussed.

Table of Contents

Executive Summary

Research Scope and Methodology 1

Research Scope and Segmentation1

Research Methodology 2

Research Overview 3

Introduction to Obesity and Anti-Obesity Drugs3

Key Findings and Analyst Insights 4

Technology Snapshot and Impact Analysis

Technology Snapshot 6

Anti-Obesity Drugs Classified on the Mode of Action6

Value Chain for Anti-Obesity Drugs 12

Assessment of Factors Influencing Adoption of Anti-Obesity Drugs 15

Market Impact of Key Drivers 15

Impact of Key Challenges and Restraints17

Regulatory Scenario 20

Diffusion of Innovations and Opportunity Evaluation

Diffusion of Innovation 23

Adoption of Anti-Obesity Drugs--North America 23

Adoption of Anti-Obesity Drugs--Europe and Asia Pacific 25

Overview of Partnerships and Alliances in the Industry 27

Opportunity Evaluation 31

Opportunity Strategy Evaluation of Anti-Obesity Drugs 31

Roadmap--Emerging Areas to Focus 34

Key Patents and Contacts

Key Patents 37

Issued Patents 37

Applied Patents40

Contacts 43

Corporate Contacts43

Academic Contacts44

D2A1 © 2011 Frost & Sullivan www frost com v

Pharmaceutical Management of Obesity

vi D2A1 © 2011 Frost & Sullivan www frost com

Decision Support Database

Decision Support Database Tables 46

Prevalence of Obese Population (2004-2014) 46

Pharmaceutical R&D Expenditure (2002-2012) 48

Total Healthcare Expenditure (2004-2014)50

To order this report:

Drug and Medication Industry: Pharmaceutical Management of Obesity (Technical Insights)

Drug and Medication Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds Machine-to-Machine (M2M) Communications in Healthcare 2010-20
2. Reportlinker Adds Hong Kong SMBG Devices and Strips Market
3. Reportlinker Adds Medical Devices Reports Bundle
4. Reportlinker Adds Impact of Healthcare Reforms on the Medical Technology Industry
5. Reportlinker Adds Pharmaceuticals Reports Bundle
6. Reportlinker Adds North America Hospital Supplies Market Outlook to 2017
7. Reportlinker Adds Asia Pacific Hospital Supplies Market Outlook to 2017
8. Reportlinker Adds Generic Growth Strategies - Manufacturers to Increase Focus on Super Generics and Biosimilars to Drive Revenues
9. Reportlinker Adds Pharmaceutical Key Trends 2011 - Socio-Demographic and Economic Overview : Rising Healthcare Costs Coupled with the Economic Downturn Continue to Shape the Healthcare Landscape
10. Reportlinker Adds Pharmaceutical Key Trends 2011 - Generics Market Overview: Patent cliff set to drive global generic uptake despite tougher market conditions
11. Reportlinker Adds Markets for Emerging Pharmaceutical Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/6/2017)... ANTONIO , Sept. 6, 2017  Robert G. ... a Pinnacle Professional Member in recognition of his contributions ... Szewc serves as a Nephrologist at the practice of ... emergency medicine, kidney care and hypertension solutions. He has ... 20 years of career experience, as well as expertise ...
(Date:9/6/2017)... Sept. 6, 2017 Eli Lilly and Company ... present new data for galcanezumab and lasmiditan, two investigational ... International Headache Society (IHC) taking place Sept. 7-10 in ... will highlight new, long-term data from an open-label study ... galcanezumab (120 mg and 240 mg) for the prevention ...
(Date:9/5/2017)... LONDON , Sept. 5, 2017  Just 18 ... Valid Insight is pleased to announce the appointment of ... Tammy Wynne , Dominic Jones-Phillips and ... from industry. ... a team of market access writers. She has over ...
Breaking Medicine Technology:
(Date:9/22/2017)... ... September 22, 2017 , ... Tiny Transitions ( tinytransitions.com ), ... in-home and online newborn sleep consultations . , “We are seeing now, ... company owner Courtney Zentz, a pediatric sleep professional, post-partum doula and certified lactation ...
(Date:9/22/2017)... (PRWEB) , ... September 22, 2017 , ... ... book on the fallacy of an obligatory tithe, and the freedom experienced when ... is the creation of published author, Lysa M. Harrison. , Published by Christian ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... you brush more effectively even on the go. Their electric toothbrushes aggressively attack ... gum inflammation, with UV sanitizing technology. Combining leading edge Enke technology with a ...
(Date:9/22/2017)... ... 22, 2017 , ... Egg freezing and embryo freezing are ... a slight statistical advantage for live births, frozen eggs offer many advantages, depending ... undergoing medical treatment or who are concerned about the decline of their fertility ...
(Date:9/21/2017)... ... September 21, 2017 , ... Process Capability Indices for Medical ... p.m. ET, http://www.fdanews.com/processcapabilityindices      , Quality in device manufacturing ... The Quality System Regulation (§820.250), and Devicemakers find themselves staring at a warning ...
Breaking Medicine News(10 mins):